| 1 |
34448875 | Acute Effects of an Inorganic Phosphorus Additive on Mineral Metabolism and Cardiometabolic Risk Factors in Healthy Subjects. | 2022 Jan 18 |
1 |
| 2 |
35613118 | Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis. | 2022 |
1 |
| 3 |
32743932 | Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study. | 2021 Jan |
1 |
| 4 |
33308018 | Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder. | 2021 Feb 1 |
1 |
| 5 |
33471363 | Parenteral iron therapy and phosphorus homeostasis: A review. | 2021 May 1 |
1 |
| 6 |
33832448 | Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis. | 2021 Apr 8 |
2 |
| 7 |
33912412 | Diagnostic value of fibroblast growth factor 23 for abdominal aortic calcification in Indonesian hemodialysis patients. | 2021 Apr-Jun |
2 |
| 8 |
34011663 | Rare PHEX variant with insidious presentation leads to a delayed diagnosis of X-linked hypophosphatemia. | 2021 May 19 |
1 |
| 9 |
34068220 | The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders. | 2021 May 13 |
1 |
| 10 |
34268038 | Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia. | 2021 Jun |
1 |
| 11 |
34659853 | A Case of Femoral Neck Insufficiency Fracture due to Tumor-Induced Osteomalacia. | 2021 |
3 |
| 12 |
34930854 | Relation Between Fibroblast Growth Factor-23 and Red Cell Distribution Width in Patients with End-Stage Renal Disease Undergoing Hemodialysis. | 2021 Dec |
2 |
| 13 |
31919781 | Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk. | 2020 Apr |
1 |
| 14 |
32418499 | Fibroblast Growth Factor 23 and Blood Pressure in Older Adults: The Health, Aging, and Body Composition Study. | 2020 Jul |
2 |
| 15 |
32901861 | Fortified phosphorus‑lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease. | 2020 Nov |
1 |
| 16 |
33015068 | Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. | 2020 |
2 |
| 17 |
33015612 | Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation. | 2020 Jan-Feb |
2 |
| 18 |
33306729 | Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study. | 2020 |
2 |
| 19 |
30465136 | Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis. | 2019 Apr |
1 |
| 20 |
31037817 | Clearance of FGF-23 during continuous renal replacement therapy. | 2019 Jul |
1 |
| 21 |
31218207 | Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF. | 2019 Mar |
1 |
| 22 |
31384956 | Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study. | 2019 Nov |
4 |
| 23 |
31599133 | FGF23 and Associated Disorders of Phosphate Wasting. | 2019 Sep |
4 |
| 24 |
31831119 | Mineral Bone Abnormalities and Vascular Calcifications. | 2019 Nov |
1 |
| 25 |
29621752 | Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline. | 2018 |
2 |
| 26 |
29633705 | Early postoperative measurement of fibroblast growth factor 23 predicts severe acute kidney injury in infants after cardiac surgery
. | 2018 Sep |
2 |
| 27 |
29660161 | The FGF-23/klotho axis and its relationship with phosphorus, calcium, vitamin D, PTH, aldosterone, severity of disease, and outcome in hospitalised foals. | 2018 Nov |
4 |
| 28 |
29669938 | Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. | 2018 Apr 19 |
2 |
| 29 |
29679282 | Burosumab: First Global Approval. | 2018 Apr |
1 |
| 30 |
29886473 | [Correlation of fibroblast growth factor 23 with
adverse prognosis of chronic kidney disease and
therapy strategy]. | 2018 May 28 |
1 |
| 31 |
30217807 | Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. | 2018 Oct |
2 |
| 32 |
30249044 | Intestinal Phosphorus Absorption in Chronic Kidney Disease. | 2018 Sep 23 |
2 |
| 33 |
30413250 | Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease. | 2018 Nov |
1 |
| 34 |
30701904 | Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration. | 2018 Jun 20 |
1 |
| 35 |
27820122 | Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions. | 2017 Jan |
1 |
| 36 |
27826644 | Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury. | 2017 Mar |
1 |
| 37 |
28110703 | Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23. | 2017 Feb |
1 |
| 38 |
28182071 | Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India. | 2017 Jan-Feb |
2 |
| 39 |
28497083 | Impact of FGF23 level on calcium and phosphorus levels in post-renal transplantation. | 2017 |
2 |
| 40 |
28619026 | Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus. | 2017 Jun 15 |
1 |
| 41 |
29179169 | [Bone remodeling through a phosphate metabolism.] | 2017 |
1 |
| 42 |
25770169 | The challenge of controlling phosphorus in chronic kidney disease. | 2016 Apr |
1 |
| 43 |
26773479 | Bone sialoprotein keratan sulfate proteoglycan (BSP-KSPG) and FGF-23 are important physiological components of medullary bone. | 2016 Apr |
1 |
| 44 |
26786148 | Consequences of a high phosphorus intake on mineral metabolism and bone remodeling in dependence of calcium intake in healthy subjects - a randomized placebo-controlled human intervention study. | 2016 Jan 19 |
1 |
| 45 |
26790456 | Novel biological markers of bone: from bone metabolism to bone physiology. | 2016 Oct |
1 |
| 46 |
26813507 | [FGF23 related hypophosphatemic rickets:current therapy and unresolved issues]. | 2016 Feb |
1 |
| 47 |
26928188 | Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type. | 2016 Jul |
2 |
| 48 |
26965530 | Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women. | 2016 May |
3 |
| 49 |
27040054 | Effects of gender and body weight on fibroblast growth factor 23 responsiveness to estimated dietary phosphorus. | 2016 |
2 |
| 50 |
27070162 | [The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease]. | 2016 |
1 |